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assessed with a 10-question quiz on PrEP facts. No incentives to complete the survey 
were offered. Data were summarized by frequency (%) for categorical variables and 
with means (SD) for continuous variables. Chi-squared tests were used to examine 
differences between knowledge of PREP and other categorical variables.
Results. The study population (N = 1588) included women (53%), non-Cauca-
sians (27%), and non-heterosexuals (15%). Median age was 25 (range 21–53). Forty-
eight home states, including D.C., and 21 home countries were represented. 18% of 
fourth-year students were never taught about PrEP in medical school, compared with 
40% of first-year students (P < 0.001). Overall, 28% of students were unaware of PrEP. 
Those unaware believed patients without HIV will not adhere to PrEP (P  <  0.001). 
Awareness was associated with knowing someone with HIV besides a patient and 
experience caring for HIV-infected, intravenous drug-using, and LGBTQ people 
(P < 0.001). Higher knowledge scores were associated with confidence in determining 
a patient’s candidacy for PrEP and, for third- and fourth-year students, having recom-
mended PrEP in the clinical setting (P < 0.001). Overally, 57% believed that behavioral 
intervention should be tried before prescribing PrEP, 45% believed that patients would 
not adhere to PrEP, and 22% worried that PrEP is not effective.
Conclusion. We show in an 18-site study that medical students have limited 
awareness, knowledge, positive beliefs, and experiences of PrEP. Given these findings 
and the underutilization of PrEP by current practitioners, we recommend increasing 
the inclusion of PrEP in medical student education.
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Background. While HIV prevention activities are often focused on younger peo-
ple, older people can also be at risk for HIV infection. We aimed to characterize HIV 
transmission in older adults.
Methods. The STOP study was a multi-site prospective study of persons with 
acute HIV infection (AHI) from 2011 to 2013. Older adults were defined as ≥45 years 
and younger persons were 13–44 years. AHI was defined by a negative rapid test but 
a reactive antigen/antibody or HIV RNA test. We performed bivariate analysis using 
Pearson’s chi-square and odds ratios to examine associations between older age and 
transmission characteristics. Among persons with HIV-1 polymerase (pol) sequences, 
transmission linkages were inferred when the genetic distance between sequences was 
<1.5% and did not indicate directionality of transmission.
Results. Among 86,836 participants (median age, 29  years; 75.0% male; 51.8% 
MSM), HIV infection was diagnosed in 176 (1.46%) of 12,036 older adults compared 
with 1,150 (1.53%) of 74,800 younger people (P = 0.56). Among HIV-infected persons, 
AHI was diagnosed in similar proportions of older and younger people (13.1% vs. 
12.6%; P  =  0.86). Among HIV-infected persons who participated in partner notifi-
cation (n = 1,326), older adults were less likely to report meeting a sex partner online 
(11.3% vs. 26.9%; OR 0.52, 95% CI = 0.35–0.78) and were less likely to name ≥2 sex 
partners (31.5% vs. 46.8%; OR = 0.28, 95% CI = 0.15–0.53) compared with younger 
people. Among HIV-infected persons with HIV-1 pol sequences (n = 537), similar pro-
portions of older and younger people had viruses that genetically linked with another 
study participant (15.9% vs. 23.5%; OR 0.62, 95% CI 0.31–1.22) (Figure).
Conclusion. In this study, older adults had a similar frequency of newly diag-
nosed HIV infection, acute infection, and genetic linkage compared with younger 
people, suggesting that increased HIV prevention efforts may be needed in this 
population.
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Background. Identifying populations with high HIV transmission rates is impor-
tant for prevention and treatment strategies. Persons with recently acquired HIV infec-
tion are drivers of HIV transmission due to high levels of HIV viral load (VL). We 
assessed annual HIV transmission rates and factors associated with recent infection to 
inform targeted interventions in a hyperendemic region in Kenya.
Methods. The Ndhiwa HIV impact assessment was a population-based survey 
among persons aged 15–59 years living in South Nyanza, Kenya in 2012. Respondents 
were tested for HIV using rapid tests per national guidelines and provided blood for 
centralized testing. Specimens from HIV+ persons were tested for VL and recent 
infection. Recent infection was defined as normalized optical density value <1.5 on 
the Limiting Antigen Enzyme Immunoassay, VL >1,000 copies/mL, and no report of 
HIV treatment. The annual HIV transmission rate per 100 persons living with HIV 
(PLHIV) was calculated as HIV incidence divided by HIV prevalence, multiplied by 
100. Annualized HIV incidence was estimated, assuming a mean duration of recent 
infection of 141 days (confidence interval [CI] 123–160). Multivariate analysis iden-
tified independent factors associated with recent infection. Estimates were adjusted 
for survey design.
Results. Of 6,076 persons tested, 1,457 were HIV+, and 28 were recently infected. 
HIV incidence and prevalence were 1.7% (CI 1.5–2.0) and 24.1% (CI 22.6–25.5), 
respectively. Per 100 PLHIV, the annual HIV transmission rate was 7.0 and varied by 
sex (4.6 male vs. 8.3 female), age (5.2 aged 30+ vs. 10.4 aged <30), and residence (1.4 
Kobama vs. 12.0 Riana vs. 12.1 Pala divisions). After controlling for age, sex, and resi-
dence, recently infected persons were significantly more likely to reside in Pala division 
(AOR 8.3, CI 1.1–62.9) than HIV-uninfected persons.
Conclusion. Approximately 7 in 100 PLHIV transmitted to HIV-uninfected per-
sons in South Nyanza in 2012, similar to national rates observed in the 2012 Kenya 
AIDS Indicator Survey. HIV transmission rates were higher in females than males, 
younger than older, and Riana and Pala than other divisions. Residence in Pala was a 
risk factor for recent infection. These findings could guide prioritization of interven-
tions to interrupt HIV transmission in this hyperendemic setting.
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Background. Individuals engaging in higher risk behavior are often more adher-
ent to PrEP but it is unclear if partnership type itself affects PrEP adherence. We exam-
ined the effect of recent HIV risk behaviors and partnership type on PrEP adherence in 
men who have sex with men (MSM) taking PrEP.
Methods. CCTG 595 is a 48-week PrEP demonstration study of 398 HIV− at-risk 
MSM. At baseline and week 48, HIV risk score was estimated as the probability of sero-
conversion over the next year based on number of condomless anal sex acts with HIV+/
unknown partners in the last month and any STI diagnosed at study visit. HIV risk score 
was categorized as low (<0.12), moderate (0.12−0.59) and high (>0.59) risk based on pop-
ulation seroconversion probabilities. Partnership type was assigned as no/single HIV− 
partner, single HIV+ partner, or multiple partners of any serostatus in the past 3 months. 
PrEP adherence was estimated by intracellular tenofovir-diphosphate (TFV-DP) levels as 
a continuous variable at week 48. Statistical methods included McNemar’s test, Wilcoxon 
rank-sum test, and linear regression model where appropriate.
Results. Of 313 MSM who completed week 48, there was no significant change in 
HIV risk category from baseline to week 48 (low: 44 to 42%; moderate: 27 to 24%; high: 
28 to 34%; P = 0.25). There was a significant change in partnership type, with the pro-
portion of those with no or single HIV− partnerships increasing (1 to 9%, P < 0.001). 
In univariate analysis, moderate and high-risk groups had higher TFV-DP levels than 
the low-risk group at week 48 (P = 0.018). Participants with no/single HIV− partner 
had significantly lower TFV-DP levels than those with one HIV+ partner or multiple 
partners (P = 0.007). In a multivariable linear regression model, only low-risk partner-
ships remained significant where no/single HIV− partnerships were associated with 
lower TFV-DP levels (mean difference = −344 fmol/punch [−617, −71], P = 0.014).
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Conclusion. Although there was a shift in partnership type towards lower risk 
partnerships, objective HIV risk behavior remained stable over time. Individuals with 
higher HIV risk behaviors and risk partnerships had higher TFV-DP levels suggesting 
maintained strong motivation for PrEP adherence. Thus, recent sexual risk behavior 
and partnership type may be important predictors of PrEP adherence in MSM.
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Background. Detection of antiretroviral (ARV) resistance in HIV-infected indi-
viduals is not uncommon and may be particularly problematic in HIV-infected preg-
nant women as it can lead to infant infection with resistant strains. To better evaluate 
the effect of drug resistance mutations (DRMs) on HIV mother-to-child transmission 
(MTCT), we determined the prevalence of DRMs in a subset of mother–infant pairs 
enrolled in a multi-center trial of infant prophylaxis among women not receiving 
ARVs during the current pregnancy.
Methods. A case–control design of 1:4 (1 transmitter to 4 nontransmitters) was 
utilized to evaluate ARV resistance as a predictor of HIV MTCT in specimens obtained 
from mother–infant pairs. Secondary objectives included identification of potential 
risk factors associated with the presence of DRMs. Viroseq HIV-1 Genotyping System 
was performed on mother–infant specimens to assess for mutations that might result 
in a substantial reduction in drug susceptibility and clinical outcome, as determined by 
the Stanford HIV Drug Resistance Database.
Results. One hundred and forty infants were infected. Of these, 123 HIV infected 
mother–infant pairs and 483 of 560 women who did not transmit HIV had amplifia-
ble HIV nucleic acid enabling ARV resistance testing. A wide variety of DRMs were 
detected (Figure 1). Sixty (10%) of 606 women had clinically relevant DRMs; 12 (2%) 
had DRMs against more than 1 ARV class. Among 123 HIV− infected infants, 13 
(11%) had clinically relevant DRMs with 3 (2%) harboring DRMs against more than 
1 ARV class. Of 13 infants with DRMs, 10 (77%) were infected in utero. In univariate 
and multivariate analyses, DRMs in mothers were not associated with increased risk of 
HIV MTCT (AOR 0.79, 95% CI 0.38–1.5). Log HIV viral load was the only predictor of 
MTCT (OR 1.4, 95% CI 1.2−1.6). The presence of DRMs in mothers who transmitted 
was strongly associated with the presence of DRMs in infants (P < 0.001).
Conclusion. In infected pregnant women without ARV exposure during their 
current gestation, the presence of pre-existing DRMs with a wide diversity was noted. 
DRMs do not increase the risk of HIV MTCT. However, if women with DRMs are not 
virologically suppressed they are likely to transmit resistant mutations even without 
selective ARV pressure, thus complicating treatment options.
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Background. PrEP, regular use of antiretroviral medications by HIV-negative indi-
viduals to prevent new HIV infections, has not been widely adopted by some young, high-
risk populations. This study investigated the characteristics and estimated percentage of 
newly diagnosed HIV-infected individuals in South Carolina (SC) who had visited a health 
care facility (HCF) while HIV-negative and missed opportunities for initiating PrEP.
Methods. We used a unique person-level identifier to link case reports from the 
SC enhanced HIV/AIDS Reporting System and records from a statewide all payer 
HCF database. The HCF data include inpatient (IP), outpatient (OP), and emergency 
department (ED) visits to SC facilities. Because the Food and Drug Administration 
approved PrEP in 2012, we analyzed data for individuals diagnosed with HIV during 
January 2013–September 2016 with initial CD4 count ≥500 cells (recent infection) and 
HC visits during 2011 through the date of diagnosis. We used the two-tailed chi-square 
statistics with a significant threshold of P < 0.05 in SAS to investigate the association 
between the absence of a PrEP prescription and patient factors including demographics, 
behavioral risk, visit setting (IP, OP or ED), frequency of previous visits, and residence 
at diagnosis.
Results. A  total of 785 patients were diagnosed with recent HIV infections (initial 
CD4 ≥500 cell) during January 2013–September 2016. Of these, 504 (64.2%) visited an SC 
HCF at least once before being diagnosed, 72.4% were males, 52.4% aged <30 years, 54% 
were men who have sex with men (MSM) or injection drug users (IDU) and 70.2% resided 
in urban areas. Mean number of HCF visits before HIV diagnosis was 6.6; 84.3% had ED vis-
its; 5.9% had IP visits; and 7.0% had OP visits. Persons of female sex, Black race, younger age 
and urban residence were more likely to access HCF visit before HIV diagnosis (P < 0.05).
Conclusion. We now know the characteristics and percentage (64.2%) of per-
sons with recent HIV infections captured in two large state-wide databases in SC who 
missed opportunities to be screened and initiated PrEP during visits to HCFs before 
HIV diagnosis during 2013–2016.
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Background. Hospital testing for respiratory pathogens is nonsystematic, leading 
to potential missed detection of clinically relevant pathogens. The Minnesota Severe 
Acute Respiratory Illness (SARI) surveillance program monitors hospitalizations due 
to acute respiratory illness and conducts systematic testing for several respiratory path-
ogens. We assessed viruses detected by the hospital and additional detections identified 
by expanded testing.
Methods. Residual upper respiratory specimens collected from patients hospital-
ized for suspected respiratory illness for routine diagnostic testing at three hospitals, 
including one children’s hospital, were submitted to the Minnesota Department of 
Health (MDH). Specimens were tested for 18 respiratory viruses by RT-PCR. Clinical 
and hospital test data were collected through medical record review.
Results. From September 2015 to August 2016, 2,351 hospitalized SARI patients were 
reported, with the following age distribution: 57% <5 years, 13% 5–17 years, 30% ≥18 years. 
Among all SARI patients, 97% (2,273) had hospital-based, clinician-directed testing for 
viral pathogens. Viruses were detected among 47% (1,077) of tested patients, among which 
testing methods included PCR (85%), rapid antigen (13%), and culture (2%); 74% were 
tested on the day of admission. Most common viruses detected by clinical testing included 
respiratory syncytial virus (41%), rhinovirus/enterovirus (31%), and influenza (15%) 
(Figure 1). Systematic RT–PCR testing at MDH identified 1,600 (68%) patients positive for 
≥1 respiratory virus, identifying previously unknown detections among 35% (820) of SARI 
patients (Figure 2). Of 1,272 patients with no virus identified at the hospital, 46% (586) had 
a viral detection at MDH. Patients aged <18 years were significantly more likely to have an 
additional pathogen detected by MDH testing than those aged ≥18 years (P < 0.01), includ-
ing rhinovirus/enterovirus, adenovirus, human metapneumovirus, and coronaviruses.
Conclusion. Systematic, expanded testing at MDH identified a higher propor-
tion of respiratory pathogens among SARI patients compared with clinical laboratory 
testing. Additional testing for clinically relevant respiratory pathogens may inform 
medical decision-making.
Figure 1.
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